Phase 3 Study of MRTX849 (Adagrasib) vs. Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-12). The gene discussed is KRAS; the disease is non-small cell lung carcinoma.